Researchers at Dartmouth-Hitchcock Norris Cotton Cancer Center are exploring ways to wake up the immune system so it recognizes and attacks invading cancer cells.
Tumors protect themselves by tricking the immune system into accepting everything as normal, even while cancer cells are dividing and spreading.
One pioneering approach, discussed in a review article published this week in WIREs Nanomedicine and Nanobiotechnology, uses nanoparticles to jumpstart the body’s ability to fight tumors. Nanoparticles are too small to imagine. One billion could fit on the head of a pin. This makes them stealthy enough to penetrate cancer cells with therapeutic agents such as antibodies, drugs, vaccine type viruses, or even metallic particles. Though small, nanoparticles can pack large payloads of a variety of agents that have different effects that activate and strengthen the body’s immune system response against tumors.
There is an expanding array of nanoparticle types being developed and tested for cancer therapy. They are primarily being used to package and deliver the current generation of cancer cell killing drugs and progress is being made in that effort.
“ Our lab’s approach differs from most in that we use nanoparticles to stimulate the immune system to attack tumors and there are a variety of potential ways that can be done,” said Steve Fiering, PhD, Norris Cotton Cancer Center researcher and professor of Microbiology and Immunology, and of Genetics at the Geisel School of Medicine at Dartmouth. “Perhaps the most exciting potential of nanoparticles is that although very small, they can combine multiple therapeutic agents.”
Read more . . .
The Latest on: Immune response stimulation
[google_news title=”” keyword=”Immune response stimulation” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Immune response stimulation
- Experts develop immune-enhancing therapies to target tuberculosison April 26, 2024 at 3:10 pm
Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body's own immune system to target tuberculosis, with hopes that they could tackle even the ...
- Common antibiotic Neosporin may shield against viral respiratory infectionson April 26, 2024 at 9:00 am
A study conducted first in mice and then in human volunteers suggests that a common antibiotic, neomycin, which is the main active ingredient in Neosporin, may help protect against viral respiratory ...
- Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024on April 25, 2024 at 5:01 am
Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, announced today ...
- Medigene presents streamlined 6-day, high stemness TCR-T therapy production processon April 25, 2024 at 2:00 am
The 4-1BB (CD137) costimulatory signaling pathway: Effective T cell immune responses to antigens typically require both a primary antigenic stimulation via the T cell receptor (TCR) and costimulatory ...
- Study could offer solution for reawakening responses from the immune systemon April 23, 2024 at 5:56 pm
Robert Clarke, PhD, executive director and professor, and Lu Jin, MS, researcher at The Hormel Institute, University of Minnesota, have co-authored a paper recently published in the journal ACS Nano.
- Scientists identify and show how to target a key tumor defense against immune attackon April 23, 2024 at 5:00 pm
A new study has discovered how a lipid molecule found at high levels within tumors undermines the anti-cancer immune response and compromises a recently approved immunotherapy known as adoptive cell ...
- Engineered Peptides Open New Avenue for Immunotherapyon April 22, 2024 at 2:24 am
The immune system is built to identify and eliminate diseased cells, but cancer cells often avoid detection. Researchers have designed a new method for developing immunotherapy drugs using engineered ...
- Researchers develop new method to boost immune cells for fighting canceron April 20, 2024 at 9:23 am
“The whole class of drugs that are employed to jump-start the immune system to fight cancer cells has largely not yet succeeded. Our goal is to create novel solutions that allow researchers to test ...
- After the Smoke Clears: Scars on the Immune Systemon April 14, 2024 at 5:00 pm
The researchers measured the production of disease-associated cytokines following exposure to stimulation conditions that targeted either the innate immune system, a pre-programmed response network ...
via Bing News